The ongoing fight over reduction mammaplasty coverage is forcing a long-overdue reckoning within maternal healthcare. Denying treatment for structural skeletal damage under the pretext of cosmetic exclusion reveals deep flaws in commercial coverage models. Forcing mothers to live with preventable spine and nerve damage is not sound medicine; it is a financial strategy designed to shift long-term care costs onto patients.
Modernizing these guidelines requires discarding decades-old formulas like the Schnur scale and respecting the clinical judgment of experienced reconstructive surgeons. When postpartum macromastia threatens a woman's physical stability, independence, and long-term musculoskeletal health, corrective surgery is not an elective luxury. It is basic, restorative medical care.
